ANI Pharmaceuticals Inc (NASDAQ:ANIP) has received an average rating of “Buy” from the seven research firms that are covering the stock, Marketbeat reports. One research analyst has rated the stock with a hold rating and five have issued a buy rating on the company. The average 1-year target price among analysts that have covered the […]
